Yifeng Pharmacy Chain Co (SHSE:603939) Cyclically Adjusted Revenue per Share: ¥13.39 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603939 Yifeng Pharmacy Chain Co Ltd SHSE:603939
93 GF Score
Price ¥22.56
GF Value ¥26.22
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Yifeng Pharmacy Chain Co Cyclically Adjusted Revenue per Share?

Yifeng Pharmacy Chain Co SHSE:603939 -1.14% 93 Cyclically Adjusted Revenue per Share is ¥13.39 as of Jun. 2026. GuruFocus rates SHSE:603939 with a GF Score™ of 93/100 and a GF Value™ of ¥26.22 (Modestly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Yifeng Pharmacy Chain Co's adjusted revenue per share for the three months ended in Jun. 2026 was ¥4.945. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ¥13.39 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Yifeng Pharmacy Chain Co's average Cyclically Adjusted Revenue Growth Rate was 15.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-09-07), Yifeng Pharmacy Chain Co's current stock price is ¥22.56. Yifeng Pharmacy Chain Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ¥13.39. Yifeng Pharmacy Chain Co's Cyclically Adjusted PS Ratio of today is 1.68.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Yifeng Pharmacy Chain Co was 4.05. The lowest was 1.40. And the median was 2.28.


Yifeng Pharmacy Chain Co  (SHSE:603939) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Yifeng Pharmacy Chain Co's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=22.56/13.39
=1.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Yifeng Pharmacy Chain Co was 4.05. The lowest was 1.40. And the median was 2.28.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Yifeng Pharmacy Chain Co Cyclically Adjusted Revenue per Share Related Terms


Yifeng Pharmacy Chain Co Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Yifeng Pharmacy Chain Co's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yifeng Pharmacy Chain Co Cyclically Adjusted Revenue per Share Chart

Yifeng Pharmacy Chain Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 9.27 10.86 12.59

Yifeng Pharmacy Chain Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.64 12.06 12.59 13.03 13.39

Yifeng Pharmacy Chain Co Cyclically Adjusted Revenue per Share Competitor Comparison

For the Pharmaceutical Retailers subindustry, Yifeng Pharmacy Chain Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yifeng Pharmacy Chain Co Cyclically Adjusted PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yifeng Pharmacy Chain Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Yifeng Pharmacy Chain Co's Cyclically Adjusted PS Ratio falls into.


SHSE:603939
93GF Score
Yifeng Pharmacy Chain Co Ltd SHSE:603939
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yifeng Pharmacy Chain Co Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Yifeng Pharmacy Chain Co's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=4.945/116.0564*116.0564
=4.945

Current CPI (Jun. 2026) = 116.0564.

Yifeng Pharmacy Chain Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.818 102.400 0.927
201612 0.978 102.600 1.106
201703 0.971 103.200 1.092
201706 1.048 103.100 1.180
201709 1.063 104.100 1.185
201712 1.250 104.500 1.388
201803 1.334 105.300 1.470
201806 1.365 104.900 1.510
201809 1.473 106.600 1.604
201812 1.999 106.500 2.178
201903 2.146 107.700 2.313
201906 2.237 107.700 2.411
201909 2.031 109.800 2.147
201912 2.499 111.200 2.608
202003 2.642 112.300 2.730
202006 3.650 110.400 3.837
202009 2.722 111.700 2.828
202012 3.206 111.500 3.337
202103 3.044 112.662 3.136
202106 3.164 111.769 3.285
202109 2.872 112.215 2.970
202112 3.670 113.108 3.766
202203 3.447 114.335 3.499
202206 3.761 114.558 3.810
202209 3.728 115.339 3.751
202212 5.489 115.116 5.534
202303 4.434 115.116 4.470
202306 4.373 114.558 4.430
202309 4.391 115.339 4.418
202312 5.511 114.781 5.572
202403 4.844 115.227 4.879
202406 4.888 114.781 4.942
202409 4.532 115.785 4.543
202412 5.225 114.893 5.278
202503 4.813 115.116 4.852
202506 4.643 114.907 4.689
202509 4.517 115.471 4.540
202512 5.821 115.832 5.832
202603 4.872 116.303 4.862
202606 4.945 116.056 4.945

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ¥13.39 mean?
Yifeng Pharmacy Chain Co (SHSE:603939) has a Cyclically Adjusted Revenue per Share of ¥13.39 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Yifeng Pharmacy Chain Co and its competitors.
Is Yifeng Pharmacy Chain Co's Cyclically Adjusted Revenue per Share too high?
Yifeng Pharmacy Chain Co's current Cyclically Adjusted Revenue per Share is ¥13.39. Overall, Yifeng Pharmacy Chain Co has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Yifeng Pharmacy Chain Co's Cyclically Adjusted Revenue per Share compare to competitors?
Yifeng Pharmacy Chain Co's Cyclically Adjusted Revenue per Share of ¥13.39 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Healthcare Providers & Services company?
A good Cyclically Adjusted Revenue per Share depends on the Healthcare Providers & Services industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Yifeng Pharmacy Chain Co and its competitors. Yifeng Pharmacy Chain Co's current Cyclically Adjusted Revenue per Share is ¥13.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yifeng Pharmacy Chain Co stock overvalued right now?
Based on GuruFocus' analysis, Yifeng Pharmacy Chain Co (SHSE:603939) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥26.22, compared to a current price of ¥22.56 — trading 14% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ¥13.39. Yifeng Pharmacy Chain Co's overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Yifeng Pharmacy Chain Co (SHSE:603939), the current Cyclically Adjusted Revenue per Share is ¥13.39 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yifeng Pharmacy Chain Co (SHSE:603939) Overvalued in 2026?

Based on GuruFocus' analysis, Yifeng Pharmacy Chain Co stock appears to be undervalued. The current stock price of ¥22.56 is trading 14% below its estimated GF Value™ of ¥26.22. GuruFocus considers Yifeng Pharmacy Chain Co to be Modestly Undervalued.

Key valuation signals for SHSE:603939:

  • Cyclically Adjusted Revenue per Share: ¥13.39
  • GF Value™: ¥26.22 vs. price of ¥22.56 (14% below fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the SHSE:603939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Yifeng Pharmacy Chain Co Business Description

Address No. 68, Jinzhou Avenue, Lugu High-tech Zone, Hunan Province, Changsha, CHN, 410000
Yifeng Pharmacy Chain Co Ltd is mainly engaged in the chain retail business of medicines, health products, medical devices, and health-related daily convenience products. Its operating segments include the Retail segment and the Wholesale segment.
93GF Score

Get the complete analysis for SHSE:603939

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥22.56
Price
¥26.22
GF Value